Android app Apple app link

Generic Drug-Focused Amneal Beats Q3 Expectations, Reaffirms Annual Forecasts

By Yahoo! Finance   |   1 year ago
Generic Drug-Focused Amneal Beats Q3 Expectations, Reaffirms Annual Forecasts

The company's Q3 sales reached $702.47 million, showing a 13% increase from the previous year. Strong growth in generic, specialty, and AvKARE net revenues drove this performance.

Read More

Did you find this insightful?

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.